2016-12-01 17:00:43 CET

2016-12-01 17:00:43 CET


SÄÄNNELTY TIETO

Englanti
Össur hf. - Changes in company's own shares

Ossur Hf : Transactions in relation to share buyback program 


Announcement from Össur hf. No. 97/2016
Reykjavík, 1 December 2016


On  3 December 2015, Össur hf.  initiated a share  buy-back program, see Company
announcement no. 48/2015. The program ended yesterday, 30 November 2016.

The following transactions were made under the program in the period 28 November
2016 - 30 November 2016:



 Date             No. of shares Avg. purchase price DKK Transaction Value DKK
-----------------------------------------------------------------------------
 28 November 2016     4,180      25.04                104,660

 29 November 2016     2,000      25.00                 50,000

 30 November 2016     12,000     24.62                295,400




-----------------------------------------------------------------------------
 Total           18,180          24.76                450,060





Össur  acquired in total 1,981,334 shares under the program at the average price
of  DKK 24.69. Following the above transactions Össur's holding of own shares is
5,793,307 corresponding to 1.30% of the Company's total share capital.

A new "Safe Harbor" share buyback program was initiated today, 1 December 2016,
on Nasdaq Copenhagen, see Company announcement no. 96/2016.



Contact persons:

Jón Sigurðsson, President & CEO                                          Tel:
+354 515 1300
Sveinn Sölvason, CFO
Tel: +354 515 1300
Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at the
following web-site: http://www.ossur.com/investormailings

About Össur Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopedics
that help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of braces, supports and prosthetic limbs. A recognized
"Technology Pioneer", Össur invests significantly in research and product
development; its award-winning designs ensuring a consistently strong position
in the market. Successful patient and clinical outcomes are further empowered
via Össur's educational programs and business solutions.  Headquartered in
Iceland, Össur has major operations in the Americas, Europe and Asia, with
additional distributors worldwide. www.ossur.com
Forward-Looking Statement This press release includes "forward-looking
statements" which involve risks and uncertainties that could cause actual
results to differ materially from results expressed or implied by these
statements. Össur hf. undertakes no obligation and does not intend to update
these forward-looking statements to reflect events or circumstances occurring
after this press release. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this press
release. All forward-looking statements are qualified in their entirety by this
cautionary statement.

[]